Life Cycle Management Services
Ensuring Compliance and Enhance Safety throughout your product Life Cycle
We assist you in regulatory action and post-approval support throughout the product life cycle to guarantee safety, compliance, and best practices in product maintenance
After receiving Marketing Authorization approval, a medicinal product must adhere to additional regulatory requirements throughout its life-cycle to ensure compliance, sustained and successful use. Zenovel, a team of specialists with extensive experience in product Life-Cycle Management, is responsible for portfolio maintenance for large, medium-sized, and small pharmaceutical and biotech companies, offering assistance in all medicinal product life-cycle management needs in the EU, USA, and other countries. We offer a complete Life cycle management solutions with regulatory strategy and maintenance support
- Our Services
Why Choose Zenovel's Life Cycle Management Services?
- Strategic Planning
We ensure efficient management of a pharmaceutical product’s life cycle, from development to maturity, to maximize value, compliance, and patient safety. This involves setting objectives, developing detailed plans, and continuously monitoring progress to adapt to market and regulatory changes.
- Regulatory Compliance
We adhere to all the regulatory laws such as UFDA, EMA, MHRA etc. by documentation, testing, monitoring, reporting adverse events, and ensuring manufacturing and marketing practices meet regulatory requirements, crucial for market approval and product presence, ensuring product safety.
- Expert Report Maintenance
We ensures accurate data presentation, thorough analysis, and regulatory alignment, facilitating approval processes, product monitoring, addressing queries, supporting lifecycle management, and promoting continuous improvement in pharmaceutical product
- Proactive Management
We conduct regular monitoring of product performance, regulatory updates, and process improvements.
People Also Ask (FAQs)
Regulatory life cycle management refers to the continuous management of regulatory submissions and compliance throughout a product’s lifecycle—from initial approval to post-approval updates. It includes activities such as variation filing, regulatory submission updates, and compliance management to ensure pharmaceutical products remain aligned with global regulatory requirements. Zenovel supports this process by managing post-approval changes, maintaining up-to-date documentation, and ensuring ongoing compliance to help products remain market-ready across their lifecycle.
Life cycle management services for pharmaceutical products help companies maintain regulatory compliance after product approval. These services support post-approval changes, variation submissions, labeling updates, and dossier lifecycle management, ensuring products continue to meet regulatory standards in global markets.
Regulatory lifecycle management covers various post-approval changes, including manufacturing updates, formulation modifications, labeling revisions, and regulatory documentation updates. These changes are typically submitted through variation filings to regulatory authorities to maintain product approval and compliance. Zenovel supports this process by managing change assessments, preparing and submitting variation dossiers, and ensuring all updates are compliant with global regulatory requirements.
Effective regulatory lifecycle management services ensure that pharmaceutical companies stay compliant with evolving regulatory requirements across multiple markets. By managing regulatory submission updates, variation filings, and post-approval documentation, companies can maintain uninterrupted product availability and regulatory approvals worldwide.
Zenovel provides comprehensive regulatory life cycle management services, including post-approval regulatory support, variation filing, dossier updates, and regulatory compliance management. Their experts help pharmaceutical companies efficiently manage regulatory changes and maintain compliance across global regulatory authorities.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
